Tempus AI, Inc.’s Lock-Up Period Set To End on December 11th (NASDAQ:TEM)

Tempus AI’s (NASDAQ:TEM) lock-up period is set to end on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its initial public offering on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Analyst Upgrades and Downgrades

TEM has been the topic of a number of research reports. Loop Capital boosted their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their price objective for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their target price on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research note on Wednesday, August 7th. Finally, Piper Sandler reiterated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Trading Down 10.6 %

Shares of TEM opened at $56.29 on Wednesday. The company’s fifty day simple moving average is $53.41. Tempus AI has a 12 month low of $22.89 and a 12 month high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Institutional Trading of Tempus AI

Institutional investors have recently made changes to their positions in the stock. EFG Asset Management North America Corp. bought a new position in Tempus AI during the second quarter valued at approximately $1,333,000. ARK Investment Management LLC purchased a new position in shares of Tempus AI in the 2nd quarter worth $18,294,000. Northwestern University bought a new stake in shares of Tempus AI in the second quarter worth $491,000. Alphabet Inc. purchased a new stake in Tempus AI during the second quarter valued at $54,289,000. Finally, Pier Capital LLC bought a new position in Tempus AI in the second quarter valued at about $2,301,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.